Press Releases Year None202020192018201720162015 Jun 19, 2020 Ovid Therapeutics Receives FDA Rare Pediatric Disease Designation for OV101 for the Treatment of Angelman Syndrome Jun 11, 2020 Ovid Therapeutics Announces Strategic Research Collaboration Focused on Accelerating the Development of New Treatments for Rare Neurological Diseases Jun 08, 2020 Ovid Therapeutics Announces Multiple Presentations on the 2020 American Academy of Neurology Science Highlights Platform Jun 04, 2020 Ovid Therapeutics Launches Pipeline Teach-In Webinar Series May 12, 2020 Ovid Therapeutics Announces Participation in the 2020 RBC Capital Markets Virtual Global Healthcare Conference Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Next page next › Last page last »
